Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Trends in Endocrinology and Metabolism: TEM|February 2, 2023
Regulation of mTOR by phosphatidic acidMaria A Frias, Ahmet Hatipoglu, David A Foster
Molecular & Cellular Oncology|September 18, 2015
(-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilizationOnica LeGendre, Paul As Breslin, David A Foster
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 9, 2003
Cost and effectiveness of glycoprotein IIb/IIIa-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary interventionPatrick L McCollam, David A Foster, Jeffrey S Riesmeyer
Cancer Letters|February 5, 2013
Inhibition of S6 kinase suppresses the apoptotic effect of eIF4E ablation by inducing TGF-β-dependent G1 cell cycle arrestPaige Yellen, Amrita Chatterjee, Angela Preda, et al.
The Journal of Biological Chemistry|July 4, 2014
Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR)David A Foster, Darin Salloum, Deepak Menon, et al.
Cell Cycle (Georgetown, Tex.)|September 1, 2015
5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cellsSuman Mukhopadhyay, Amrita Chatterjee, Diane Kogan, et al.
Cell Cycle (Georgetown, Tex.)|May 7, 2015
Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycleMahesh Saqcena, Deven Patel, Deepak Menon, et al.
Molecular Cancer Therapeutics|January 18, 2014
Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycinDarin Salloum, Suman Mukhopadhyay, Kaity Tung, et al.
Pageof 8